Digital biomarkers could fundamentally change MS care: A study shows that wearables and smartphone tests reliably map disability (EDSS) and fatigue (FSMC) in everyday life. Motor performance data and heart rate variability allow progression to be detected earlier and could make treatment decisions much more precise in future.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Acute nonspecific back pain
Implementing a biopsychosocial approach
- Neuropathic Pain
Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
- Psychedelic-assisted therapy
Current status of PAT
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Juvenile Idiopathic Arthritis
Early Detection and Targeted Treatment in an Interdisciplinary Setting
- Disorders of the Gut-Brain Interaction
Rome V Criteria: What Has Changed, and What Has Remained the Same?
- Tourette Syndrome
What can be done to treat this tic disorder?
- Chronic Hepatitis B: Is a Cure in Sight?